WEBSITECHANGES

Website Changes

---

04/18/2014

Stereotactic biopsy of brainstem lesions: Techniques, efficacy, safety, and disease variation between adults and children: A single institutional series and review.

---

04/18/2014

"Brain Tumor Forum" patient conference

---

04/16/2014

ERGO: A pilot study of ketogenic diet in recurrent glioblastoma.

---

04/16/2014

Additive homeopathy in cancer patients: Retrospective survival data from a homeopathic outpatient unit at the Medical University of Vienna.

---

04/16/2014

New Clinical Trials Finder on Virtualtrials.com

---

04/13/2014

Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared to temozolomide-chemoradiation for unresectable glioblastoma. Final results of the TEMAVIR study from ANOCEF.

---

04/12/2014

Interim Clinical Data for Tocagen`s Toca 511 & Toca FC in Patients with High Grade Glioma

---

04/12/2014

Influenza vaccine immunogenicity in patients with primary central nervous system malignancy.

---

04/12/2014

Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy.

---

04/12/2014

Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy

---

04/09/2014

IBTA Newsletter

---

04/09/2014

Fractionated stereotactic radiosurgery with concurrent temozolomide chemotherapy for locally recurrent glioblastoma multiforme: a prospective cohort study.

---

04/08/2014

Integrin Inhibitor Suppresses Bevacizumab-Induced Glioma Invasion.

---

04/06/2014

Researchers successfully treat brain tumor with sound waves

---

04/04/2014

Novocure to Present New Pre-Clinical Data on NovoTTF™ Therapy at the American Association for Cancer Research Annual Meeting 2014

---

04/03/2014

Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4 and PD-L1 in mice with brain tumors.

---

04/03/2014

Northwest Bio Warns FDA May Throw Out Phase III Brain Cancer Study

---

03/30/2014

Phase II Trial of 7days on/7 days off temozolmide for recurrent high-grade glioma.

---

03/27/2014

Scientists find treatment to kill every kind of cancer tumor

---

03/27/2014

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

---

03/27/2014

Musella Foundation is pleased to receive a $1,000 grant from The Allstate Foundation

---

03/27/2014

Inhibitory Effect of Disulfiram/Copper Complex on Non-small Cell Lung Cancer Cells.

---

03/24/2014

The Amazon Smile Foundation will donate an extra $5 to the Musella Foundation for each shopper!

---

03/24/2014

Changes to the Musella Foundation Website: "Clinical Trials And Noteworthy Treatments For Brain Tumors"

---

03/22/2014

FDA agrees to let patients get controversial drug

---